{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:46:54Z","timestamp":1792169214573,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is characterized by aggressive metastatic progression and poor clinical outcomes. During metastatic dissemination, detached tumor cells must overcome anoikis, a form of apoptosis induced by loss of extracellular matrix attachment. Although anoikis resistance is considered a critical prerequisite for metastasis, the adaptive mechanisms supporting detached survival in pancreatic cancer remain incompletely understood. In this study, anoikis-resistant (AR) pancreatic cancer cell models were established through repeated long-term suspension culture using Capan-1 and PSN-1 cells. Transcriptomic profiling was performed to identify conserved molecular programs associated with anoikis resistance in PDAC. Gene set variation analysis (GSVA) demonstrated consistent transcriptomic enrichment of autophagy-associated and suppression of cell cycle-related pathways in both AR models. Differential expression and integrative pathway analyses further identified several core genes associated with autophagy regulation and cytokine signaling. Survival analysis revealed that elevated expression of UBC and ATG14 was associated with poor prognosis in pancreatic cancer patients. Our findings suggest that suspension-selected pancreatic cancer cells undergo coordinated stress-adaptive transcriptional remodeling characterized by enriched autophagy- and ubiquitin-associated transcriptional programs.<\/jats:p>","DOI":"10.1186\/s12885-026-17107-7","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:48:27Z","timestamp":1791863307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic profiling reveals autophagy-associated programs and prognostic biomarkers in anoikis-resistant pancreatic cancer cells"],"prefix":"10.1186","volume":"26","author":[{"given":"Lizhi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Bauden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"17107_CR1","first-page":"e70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76:e70043.","journal-title":"CA Cancer J Clin"},{"key":"17107_CR2","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.","journal-title":"Nat Rev Dis Primers"},{"key":"17107_CR3","first-page":"e70035","volume":"76","author":"A Mannucci","year":"2026","unstructured":"Mannucci A, Goel A. Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future. CA Cancer J Clin. 2026;76:e70035.","journal-title":"CA Cancer J Clin"},{"key":"17107_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349\u201361.","journal-title":"Cell"},{"key":"17107_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cell.2011.11.060","volume":"148","author":"H Haeno","year":"2012","unstructured":"Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 2012;148:362\u201375.","journal-title":"Cell"},{"key":"17107_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619\u201326.","journal-title":"J Cell Biol"},{"key":"17107_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrc3789","volume":"14","author":"CL Buchheit","year":"2014","unstructured":"Buchheit CL, Weigel KJ, Schafer ZT. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014;14:632\u201341.","journal-title":"Nat Rev Cancer"},{"key":"17107_CR8","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013;1833:3481\u201398.","journal-title":"Biochim Biophys Acta"},{"key":"17107_CR9","doi-asserted-by":"publisher","first-page":"189498","DOI":"10.1016\/j.bbcan.2025.189498","volume":"1880","author":"M Corsini","year":"2025","unstructured":"Corsini M, Domenichini M, Moreschi E, Mitola S. The mechanics of anoikis resistance in cancer. Biochim Biophys Acta Rev Cancer. 2025;1880:189498.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"17107_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226:380\u201393.","journal-title":"J Pathol"},{"key":"17107_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0955-0674(00)00251-9","volume":"13","author":"SM Frisch","year":"2001","unstructured":"Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol. 2001;13:555\u201362.","journal-title":"Curr Opin Cell Biol"},{"key":"17107_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485:661\u20135.","journal-title":"Nature"},{"key":"17107_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature08268","volume":"461","author":"ZT Schafer","year":"2009","unstructured":"Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 2009;461:109\u201313.","journal-title":"Nature"},{"key":"17107_CR14","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1074\/jbc.TM117.000260","volume":"293","author":"MA Hawk","year":"2018","unstructured":"Hawk MA, Schafer ZT. Mechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment. J Biol Chem. 2018;293:7531\u20137.","journal-title":"J Biol Chem"},{"key":"17107_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2017.04.009","volume":"3","author":"JA Mason","year":"2017","unstructured":"Mason JA, Hagel KR, Hawk MA, Schafer ZT. Metabolism during ECM detachment: achilles heel of cancer cells? Trends Cancer. 2017;3:475\u201381.","journal-title":"Trends Cancer"},{"key":"17107_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818\u201322.","journal-title":"Science"},{"key":"17107_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.14348\/molcells.2017.0115","volume":"40","author":"CH Ji","year":"2017","unstructured":"Ji CH, Kwon YT. Crosstalk and interplay between the ubiquitin-proteasome system and autophagy. Mol Cells. 2017;40:441\u20139.","journal-title":"Mol Cells"},{"key":"17107_CR18","doi-asserted-by":"publisher","first-page":"166884","DOI":"10.1016\/j.bbadis.2023.166884","volume":"1870","author":"W Yang","year":"2024","unstructured":"Yang W, Wang S, Tong S, Zhang WD, Qin JJ. Expanding the ubiquitin code in pancreatic cancer. Biochim Biophys Acta Mol Basis Dis. 2024;1870:166884.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"17107_CR19","first-page":"102280","volume":"44","author":"L Lin","year":"2025","unstructured":"Lin L, Norrsell R, Andersson R, Shen X, Ansari D. Prognostic model establishment and immune microenvironment analysis based on transcriptomic data of long-term survivors of pancreatic ductal adenocarcinoma. Biochem Biophys Rep. 2025;44:102280.","journal-title":"Biochem Biophys Rep"},{"key":"17107_CR20","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","volume":"78","author":"X Niu","year":"2025","unstructured":"Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updat. 2025;78:101170.","journal-title":"Drug Resist Updat"},{"key":"17107_CR21","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1158\/1078-0432.CCR-15-0490","volume":"21","author":"E White","year":"2015","unstructured":"White E, Mehnert JM, Chan CS. Autophagy, metabolism, and cancer. Clin Cancer Res. 2015;21:5037\u201346.","journal-title":"Clin Cancer Res"},{"key":"17107_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1101\/gad.2016111","volume":"25","author":"S Yang","year":"2011","unstructured":"Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011;25:717\u201329.","journal-title":"Genes Dev"},{"key":"17107_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature19084","volume":"536","author":"CM Sousa","year":"2016","unstructured":"Sousa CM, Biancur DE, Wang X, Halbrook CJ, Sherman MH, Zhang L, et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016;536:479\u201383.","journal-title":"Nature"},{"key":"17107_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-019-0368-8","volume":"25","author":"KL Bryant","year":"2019","unstructured":"Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019;25:628\u201340.","journal-title":"Nat Med"},{"key":"17107_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/ncb0910-836","volume":"12","author":"C Kraft","year":"2010","unstructured":"Kraft C, Peter M, Hofmann K. Selective autophagy: ubiquitin-mediated recognition and beyond. Nat Cell Biol. 2010;12:836\u201341.","journal-title":"Nat Cell Biol"},{"key":"17107_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tcb.2015.08.010","volume":"26","author":"A Khaminets","year":"2016","unstructured":"Khaminets A, Behl C, Dikic I. Ubiquitin-dependent and independent signals in selective autophagy. Trends Cell Biol. 2016;26:6\u201316.","journal-title":"Trends Cell Biol"},{"key":"17107_CR27","doi-asserted-by":"publisher","first-page":"1304639","DOI":"10.3389\/fmolb.2023.1304639","volume":"10","author":"S Lv","year":"2023","unstructured":"Lv S, Zhang J, Peng X, Liu H, Liu Y, Wei F. Ubiquitin signaling in pancreatic ductal adenocarcinoma. Front Mol Biosci. 2023;10:1304639.","journal-title":"Front Mol Biosci"},{"key":"17107_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01538-4","volume":"21","author":"S Qi","year":"2022","unstructured":"Qi S, Guan X, Zhang J, Yu D, Yu X, Li Q, et al. Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis. Mol Cancer. 2022;21:70.","journal-title":"Mol Cancer"},{"key":"17107_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05962-6","volume":"22","author":"J Gu","year":"2024","unstructured":"Gu J, Xiao X, Zou C, Mao Y, Jin C, Fu D, et al. Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. J Transl Med. 2024;22:1135.","journal-title":"J Transl Med"},{"key":"17107_CR30","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1038\/sj.emboj.7601722","volume":"26","author":"KY Ryu","year":"2007","unstructured":"Ryu KY, Maehr R, Gilchrist CA, Long MA, Bouley DM, Mueller B, et al. The mouse polyubiquitin gene UbC is essential for fetal liver development, cell-cycle progression and stress tolerance. EMBO J. 2007;26:2693\u2013706.","journal-title":"EMBO J"},{"key":"17107_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev-biochem-061516-044820","volume":"86","author":"JH Hurley","year":"2017","unstructured":"Hurley JH, Young LN. Mechanisms of autophagy initiation. Annu Rev Biochem. 2017;86:225\u201344.","journal-title":"Annu Rev Biochem"},{"key":"17107_CR32","doi-asserted-by":"publisher","first-page":"108190","DOI":"10.1016\/j.jbc.2025.108190","volume":"301","author":"L Li","year":"2025","unstructured":"Li L, Fan Z, Liu M, Dong H, Li J, Li Y, et al. USP1 promotes pancreatic cancer progression and autophagy by deubiquitinating ATG14. J Biol Chem. 2025;301:108190.","journal-title":"J Biol Chem"},{"key":"17107_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01237-y","volume":"19","author":"C Zhou","year":"2020","unstructured":"Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes. Mol Cancer. 2020;19:118.","journal-title":"Mol Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-17107-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-17107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-17107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:00Z","timestamp":1792166220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-17107-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["17107"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-17107-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used established pancreatic cancer cell lines and publicly available, de-identified RNA sequencing datasets. The Swedish Ethical Review Authority approved the study protocol and waived the need for written informed consent from the participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1241"}}